Clinical Trial Update: A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating KC1036 versus investigator's choice chemotherapy in advanced esophageal squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• KC1036

Snippet

Sponsor: Beijing Konruns Pharmaceutical Co., Ltd. | Conditions: Esophageal Squamous Cell Carcinoma | Phase 3 | Status: RECRUITING